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This review discusses the advantages of using luminescent d6-transition-metal complexes as cell probes 
for optical microscopy.  In particular it focusses on the Thomas group’s use of specific complexes as 
“building blocks” toward the construction of biomolecular binding substrates, with DNA being a 
particular target.  Using this approach, a range of new imaging probes for conventional optical 
microscopy, nanoscopy and transmission electron microscopy have been identified. Through selection of 10 
specific metal centres and by substitution of coordinated ligands we illustrate how new 
chemotherapeutics, photo-therapeutics, and theranostics have been identified and developed from  the 
original architectures.  
Introduction 
Barnet Rosenberg’s discovery that cisplatin, a simple coordination 15 
complex first described in 1845, possessed potent 
chemotherapeutic action was a revelation.1 By the 1980s cisplatin 
was in clinical use as an antineoplastic drug throughout the world 
and two other derivatives eventually gained global approval. 2,3 
Consequent studies revealed that these compounds derive their 20 
therapeutic action through irreversibly binding to nuclear DNA. 4-
6 Even today, platins are used to treat a wide-range of cancers with 
around half of all chemotherapy schedules including a platin. 7,8 
 In their original report on the anti-tumour properties of cisplatin, 
Rosenburg and colleagues observed that; “at present, inorganic 25 
chemistry is largely unexplored for this property.” 1  Yet - despite 
this observation and the success of the platins – research into the 
biological activity of other platinum group metals was still slow to 
develop.  
 It was not until the Barton group’s trail-blazing work from the 30 
1980s onward9-11 that ruthenium began to attract sustained 
attention. After demonstrating that polypyridyl ruthenium 
complexes could interact reversibly with DNA, the group 
identified the striking properties of [Ru(bpy)2dppz]2+ (where bpy 
= 2,2’-bipyridine, dppz = dipyrido[3,2-a:2’,3’-c]phenazine), which 35 
became known as the “DNA light-switch”. 12 This complex is non-
emissive in protic solvents, with the expected Rudppz-based 
metal-to-ligand charge-transfer, 3MLCT, emission being non-
radiatively quenched by hydrogen bonding interactions with 
solvent molecules. 13 On the addition of B-DNA the extended dppz 40 
ligand intercalates into the duplex and the emission from the 
complex is “switched on” as its solvent accessibility is greatly 
reduced. Subsequent work on this complex, and its 1,10-
phenanthroline (phen) derivative, revealed that chirality played a 
part in this recognition process.  45 
  Hiort, et al, were the first to separate the two enantiomers of 
[Ru(phen)2dppz]2+ and show that, while there is not a large 
difference in their DNA binding affinity, the quantum yield for 
DNA-bound -[Ru(phen)2dppz]2+ is around an order of 
magnitude larger than its -analogue. Intriguingly, they also found 50 
that both bound enantiomers display two emission lifetimes. It was 
postulated that these effects were due to differences in binding 
geometries. 14  Recently, a series of definitive X-ray studies from 
Cardin and co-workers have cast light onto this hypothesis.  
 Duplex bound structures exclusively containing -55 
[Ru(phen)2dppz]2+ and -[Ru(phen)2dppz]2+. or a mixture of both 
enantiomers, have been reported and - although the bound 
enantiomers do show a variety of motifs – those involving the -
form display the greatest “solvent shielding” of the dppz ligand.15-
17 60 
 Despite these exciting properties - seen from the perspective of 
developing biological probes or therapeutic leads - the original 
DNA light-switch system is not perfect. Drawbacks include the 
low selectivity of the light-switch effect. In terms of sequence 
effect with duplex DNA, binding to AT sequences produce a red 65 
shift in emission of ~15 nm compared to GC analogues and there 
is evidence of a binding preference for extended AT sequences. 18 
In terms of structure, although binding to A-DNA and folded RNA 
only induces an insubstantial increase in luminescence, a light-
switch effect still occurs on binding to single-, triple- and 70 
quadruple-stranded DNA as well as Z-form duplex and the 
interpenetrated i-motif18-21 Furthermore, a similar emission 
enhancement is observed on binding to micelles, 22 and even 
pathogenic peptide and protein aggregates. 23,24 More importantly, 
the take up of these complexes by live cells is generally poor. Even 75 
though lipophilic derivatives passively diffuse into cells, they 
preferentially localize within the cytoplasm25 and localization 
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within the nucleus can only be accomplished by covalent 
attachment to nuclear targeting moieties. 26,27 
 With an original aim of amplifying chiral effects in DNA 
recognition, Nordén, Lincoln, and co-workers synthesized a series 
of dinuclear complexes containing linked [Ru(LL)2dppz]2+ units 5 
(LL = bpy or phen). 28-31 Studies over the last two decades have 
illustrated the fascinating properties of these architectures. As the 
two RuII(LL)2 units are tethered together at the dppz moiety these 
complexes can only intercalate into DNA through a threading 
interaction. This means they display very high binding affinities 10 
and extremely slow dissociation kinetics. The nature of this 
threading interaction is also affected by how closely the two 
RuII(LL)2 are tethered together. Longer linkers allow each 
[Ru(LL)2dppz]2+ centre to insert into a separate site resulting in 
bis-intercalation, 29,32 but directly linked [RuII(LL)2dppz] centres 15 
act as a single unit and mono-intercalate. 33 As a result, like their 
mononuclear analogues, the stereoisomers of threaded bis-
intercalators display little difference in binding parameters and 
preferences, whereas the threaded mono-intercalators show a 
kinetic binding preference for AT-rich sequences, an effect which 20 
is further amplified by chirality as selectivity is particularly 
pronounced for the  form of the bpy complex. 34,35 
 Complexes that display the light-switch effect have an obvious 
application in microscopy.  Optical microscopy is a vital technique 
for research in wide range of fields including cytology, molecular 25 
biology, medicine, and diagnostics. In this context, emission-based 
microscopes using luminescent dyes provide optimal contrast, thus 
providing high sensitivity and image resolution. Consequently, 
driven by the need to image individual cell components, the 
identification of luminescent probes that bind to intracellular 30 
targets with high specificity has become an important aim of 
research.36  
 Recent work has also demonstrated that d8-metal complexes are 
well-suited to for this form of microscopy. For example, the 
excited state of complexes like the DNA light-switch complex are 35 
emissive from triplet states (formally phosphorescence) and thus 
have large Stokes shifts and long-lived luminescence.36-38 Through 
their octahedral coordination geometry they also provide a 3-D 
“scaffold” to arrange ancillary ligands into recognition motifs.39,40 
Therefore, the Thomas group has been looking at develop systems 40 
that could incorporate some of the attractive properties displayed 
by the oligonuclear complexes described above. 
A modular approach to bis-intercalators 
Inspired by the research described in the previous section, the 
Thomas group first set out to develop a more modular approach 45 
toward the construction of dinuclear complexes based on the 
RuII(dppz) intercalative platform. A two-step method involving the 
coordination of a bridging ligand to suitable mononuclear 
“building blocks” was identified – Scheme 1.  
 Complexes with facially coordinated ligands were deliberately 50 
chosen for two reasons. First, it simplifies the synthesis of 
oligomeric structure as it leads to achiral geometries, removing the 
need to separate stereoisomers, often a laborious task – although 
chirality can be consequently added selectively using specific 
ligands. Second, linking of such units by a suitable bridging ligand 55 




Scheme 1. Generalised synthetic route to the construction of structural 60 
complex bis-intercalating systems based on M(dppz) centres and 
analogues. 
Identifying suitable building blocks 
 One suitable starting point already existed; during 1995 the 
Schanze and Yam groups both reported on the DNA binding 65 
properties of [Re(CO)3(L)dppz]+ (L = pyridine or 4-picoline), 
synthesized from [ReCl(CO)5]. 41,42 This complex does not display 
a true light-switch effect as it only show a ×13 enhancement in 
emission and, because it is a monocation, it binds DNA with an 
order of magnitude lower affinity. Nevertheless, it is of great 70 
interest as its excited state is strongly photo-oxidizing and so it is 
capable of generating DNA damage on intercalation. 43 
 
Fig. 1 structure of 12+ and 22+ 
 The first new synthetic target was a suitable RuII(dppz) building 75 
block. This was obtained by adapting a method the Meyer group 
used to create a series of complexes such as [RuCl(tpm)(phen)]+ 
(where tpm = tris(pyrazolyl)methane).44 Using 
[RuCl(tpm)(dppz)]+ as a “building block” we initially synthesized 
mononuclear dications 12+ and 22+ - Fig. 1. Studies revealed that, 80 
like the parent complex, 12+ and 22+ display a full light-switch 
effect and bind to CT-DNA with comparable affinities. Yet, further 
experiments showed that the binding selectivity of 12+ differs to 
that of [Ru(LL)2dppz]2+. 
 Previous photophysical and biophysical experiments indicated 85 
that the parent [Ru(bpy)2dppz]2+  complex displays a preference 
for AT tracks. For example, the wavelength of its emission on 
binding to mixed sequences is close to that observed when it is 
bound to synthetic AT oligonucleotides. Furthermore, AT-bound 
complexes display longer excited-state life-times (~300-800ns) 90 
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than when bound to GC sequences (~200- 400ns). Both these 
observations indicate the complex is more deeply intercalated into 
AT steps. Indeed, analysis of data obtained when ∆-
Ru(phen)2dppz
2+ was added to a 1:1 mixture of poly d(AT) and 
poly d(GC), indicated an ∼85% binding preference for poly d(AT). 5 
45  
 In contrast to these observations, isothermal calorimetry (ITC) 
studies on 12+ show that it has an order of magnitude binding 
preference for GC- over AT-sequences. Moreover, although 
previous ITC experiments had shown that intercalation of 10 
Ru(phen)2dppz
2+ into duplex DNA is an endothermic, entropically 
driven event46 - and an almost identical thermodynamic signature 
is observed when 12+ binds to poly(dA)·poly(dT) - the interaction 
of 12+with poly(dG)·poly(dC) shows a much lower favourable 
entropy change and is actually an exothermic process.  This 15 
suggests that the ancillary ligands of 12+ make favourable contacts 
with base residues within the poly(dG)·poly(dC) duplex.   
Homometallic dinuclear M(dppz) complexes 
Using Scheme 1 as a starting point, we then looked at ways to 
connect these building blocks and began by focusing on simple 20 
homo-metallic systems. This first led to the isolation of 32+ Fig. 2, 
which showed interesting binding properties. 
 
Fig 2 Structures of dinuclear ReI complex 32+ 
 Contrary to the scheme, we found that 32+ could only be isolated 25 
by linking the two ReI centres together first and then coordinating 
the dppz ligands in a second step. 47 Although the dinuclear 
complex is not luminescent, bands in its absorption spectrum 
display hypochromic changes on addition of DNA characteristic of 
intercalative interactions. Titrations based on these changes 30 
revealed that the complex binds to duplex DNA in two steps.  
 The first phase of binding occurs up to [DNA]:[complex] 
mixing ratios of around 10:1; interestingly, apparent saturation for 
this event occurs when the percentage hypochromicity is half that 
observed for its mononuclear analogues. Fits of these data to the 35 
well-established McGhee-von Hippel model resulted in a slightly 
larger binding affinity (Kb = 7 3 x105 mol-1 dm3) and site size (4.5 
base pairs, bp, compared to 3.2 bp). When more DNA was added, 
further hypochromicity was observed, resulting in a much 
shallower binding curve that did not reach saturation, even at 40 
higher [DNA]:[complex] ratios. 
 These data suggest that 32+ initially mono-intercalates and its 
binding is enhanced compared to the mononuclear analogues by its 
increased cationic charge. The second event was attributed to a 
non-specific interaction and, as it only occurs at high DNA 45 
concentrations, it seems that this may be due to inter-strand 
binding. 
 
Fig 3 Mononuclear complex 42+ is an intermediate in the synthesis of 
dinuclear RuII complex 54+ and Heterometallic RuII/ReI complex 63+ 50 
 We then explored the synthesis of similar RuII(dppz) systems. 
In this case, to increase the likelihood of bis-intercalation into the 
same duplex strand, we chose to use a slightly longer linker. So, 
using the route outlined in Scheme 1, complex 42+ was used to 
synthesize 54+ - Fig 3. Unlike 32+ complexes 42+ and 54+ do display 55 
a light-switch effect and emission titrations with 54+ indicated it 
binds to DNA monophasically with an increased Kb of 2.1 x106 
mol-1 dm3. Nonetheless, this figure is still appreciably lower than 
those of their threading analogues. To explore these issues in more 
detail, we went on to investigate the binding properties of 54+ using 60 
isothermal calorimetry, ITC.  
 The interaction of 54+ and mononuclear 42+ with both 
poly(dA)‚poly(dT) and poly(dG)‚poly(dC) were compared. These 
studies confirmed that 54+ does bind to duplex structures in a single 
phase and, notably, the binding site sizes for 54+ are appreciably 65 
larger than those for 42+; for example, the calculated site sizes for 
the two complexes with poly(dA)‚poly(dT) are 7.6 bp and 3.3 bp 
respectively. Furthermore, although both of the complexes display 
endothermic, entropically-driven interactions and their binding 
free energy changes are similar, there are distinct differences. 48  70 
 Whilst its selectivity is reduced compared to 12+, complex 42+ 
still binds to poly(dG)‚poly(dC) with an affinity that is 
approximately ×2 higher than that for poly(dA)‚poly(dT). Yet, 
within experimental error, complex 54+ shows no difference in its 
binding affinity for the two oligonucleotides. Strikingly, the 75 
favourable TS contributions for binding of 54+ to both sequences 
are bigger than those for the mononuclear complexes, but this is 
balanced by a corresponding increase in the opposing H term. 
A heterometallic dinuclear M(dppz) complex 
Again, using complex 42+ as a building block, Scheme 1 provided 80 
a convenient route toward the first ReI(dppz)/RuII(dppz) complex, 
63+, in which the metal centres are linked with the same tether 
ligand used in 54+ - Fig 3.49  
 The inclusion of the ReI(CO)3(dppz) moiety within 63+ meant 
that its excited state dynamics could be probed by time-resolved 85 
infra-red, TRIR, spectroscopy.  This technique showed that photo-
excitation initially led to the population of a dppz-centered * 
3IL state observed in mononuclear [Re(CO)3(L)dppz]+ complexes. 
In the mononuclear systems, TRIR studies had shown that the 3IL 
state then decays into a Re(d)dppz(*) MLCT manifold. In 90 
equivalent experiments with 63+ only 3IL state decay was observed. 
Furthermore, steady-state photophysical studies on this system 
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showed that excitation of the ReI(dppz) unit solely results in 
RuII(dppz)-based emission. Taken together these experiments 
indicate energy transfer from the ReI to the RuII centre, a 
phenomenon that has been observed in other ligand bridged RuII-
ReI complexes.  5 
 As might be expected from the observations described above, 
on addition of CT-DNA, 63+ displays a Rudppz-based 3MLCT 
light-switch effect with a lifetime that is comparable to 42+. The 
binding affinity of 63+, calculated from these emission changes is 
comparable to 54+ which is an order of magnitude higher than 10 
[Re(CO)3(py)dppz]+. Given that; the excited state of the latter 
complex can photo-damage DNA, complex 63+ displays an 
improved binding affinity compared to mononuclear complexes, 
and the irradiation of 63+ leads to the population of the dppz-
centered * 3IL state associated with photo-oxidation, the 15 
DNA photo-nicking properties of 63+ were also investigated. 
 It was found that addition of 63+ to aqueous buffer solutions of 
pBR322 plasmid DNA followed by photo-irradiation led to the 
generation of relaxed singly nicked plasmid and at higher loadings 
of the complex complete degradation of the DNA rapidly occurred. 20 
These observations confirmed that the complex could 
simultaneously function as a DNA light switch and a photo-
activated “scissors” for DNA. 
Exploring steric and electronic effects in mononuclear building 
blocks 25 
Despite displaying promising physical and biophysical properties, 
which included larger binding site sizes, the fact that the first 
generation of linked dinuclear complexes displayed DNA binding 
affinities that were comparable to their mononuclear analogues 
was disappointing. Simple thermodynamic considerations suggest 30 
that binding constants for bis-intercalators should be the square of 
their monomeric analogues. 50 As outlined above, a comparison of 
ITC-based DNA binding data for 42+ and 54+ showed that the 
dinuclear complex actually displays a larger unfavourable ΔH term 
compared to its mononuclear analogue, resulting in very similar 35 
binding free energies for the two complexes. This hinted that 
unfavourable steric interactions may have a deleterious influence 
on the binding of the dinuclear complex, Further evidence for this 
hypothesis came from experiments on derivatives of 22+ that led to 
very surprising observations.  40 
 
Fig 4 Mononuclear RuII complexes 72+ - 92+ 
 When we compared 72+, 82+, and 92+, Fig. 4, we found that, as 
expected, 72+ and 82+ possess DNA binding properties that are very 
similar to 12+; for example, they show a DNA light-switch effect 45 
when binding to a duplex due to a intercalative interaction and - 
although the binding affinity of 72+ is slightly reduced compared to 
the parent complex (presumably due to the increased steric demand 
produced by the methyl group of the coordinated picoline ligand) 
- it still possesses a Kb  (> 106 M-1) that approximates that of other 50 
mononuclear Ru(dppz) systems. Unexpectedly, we found that 
complex 92+ displays very different binding properties.  
 Despite the complex still exhibiting bright 3MLCT-based 
emission in non-aqueous solvents, in water - even in the presence 
of excess DNA – its light-switch remains “switched off.”  55 
Titrations based on changes of its absorbance spectrum confirmed 
that the complex does bind DNA, but its binding affinity is an order 
of magnitude lower than that of 22+ and 82+. Significantly, viscosity 
experiments revealed that 92+ is no longer a DNA intercalator. 
These observations were explained through a combination of 60 
computational and NMR-based studies. 
 Using quantum-based, density functional theory (DFT) the 
structural and electronic properties of 22+, and 72+ - 92+ were 
compared. It was found that, in all cases, the pyridyl ligand in these 
complexes is held so that its plane lies parallel to the long axis of 65 
the complex and a significant activation barrier against rotation 
away from this conformation exists. However, significant 
differences between the complexes was revealed in a comparison 
of rotational freedom around their Py-NH2 and Py-Me bonds, 
respectively. In contrast to 72+,
 
where the Py-Me bond has a low 70 
torsional barrier for rotation, calculations on 92+ suggested that the 
lone pair of the amino group is not specifically located on the 
nitrogen and there is also a large rotational barrier around the NH2-
py bond. Both these results are indicative of a large contribution 
from a quinoidal structure for the coordinated ligand, as a 75 
consequence the flat NH2 unit is held in the same plane as the 
pyridine ring, parallel to the long axis of the dppz ligand.  
 Thanks to a collaboration with Mike Williamson, an NMR-
based structure of 22+ bound to the octanucleotide 
d(CGAGCTCG)2 sequence was obtained which provided further 80 
insights into the unusual binding properties of  92+ - Fig 5.  
 
Fig. 5 Left: NMR-based structure for the major conformation of 22+ 
intercalated from the minor groove into the sequence d(CGAGCTCG)2. 
Right: View from above with the final base-pair step above the 85 
intercalation site (shown in a space filling mode), revealing the close 
contact between this step and the 4-H of the py ligand of 22+, highlighted 
in cyan. Adapted from Reference 51 with permission. (Biological 
Magnetic Resonance Data Bank Entry 16291) 
 It was found that the complex intercalates from the minor 90 
groove with the dppz inserted into the G3–A3 step. In the main 
binding geometry, the axial pyridine ligand points toward the 
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terminal base pairs and the coordinated tpm points toward the 
centre of the duplex. The structural model derived from the NMR 
data shows that the C1–G8 base pair forms a ledge that protrudes 
exactly level with the 4-H of the py ligand of 12+, suggesting that 
functional groups in the 4-position of py-based ligands could 5 
indeed hinder intercalative binding by related derivatives.51 
 Taken with the DFT calculations, it seems that during 
intercalation the 4-methyl group of 72+
 
can rotate to minimize 
unfavourable steric interactions with closely positioned DNA 
residues. Contrastingly, if 92+ intercalated with a similar geometry 10 
its coordinated 4-NH2py ligand would be held rigidly in in a 
sterically unfavourable position; consequently, groove binding 
becomes the energetically favoured binding mode. Variable 
temperature experiments on 22+ and 92+ revealed another facet of 
this fascinating phenomenon. 15 
Temperature dependent binding modes 
 At first, the DNA binding thermodynamics of the two 
complexes at 25°C was investigated. It was found that in these 
conditions binding is entropically driven, but though the 
interaction involving 22+ is an endothermic process, there is no heat 20 
change associated with the interaction of 92+. Then similar 
experiments at 10°C and 35°C were carried out to obtain estimates 
of ∆Cp.. The data obtained for 22+ yielded an estimated ∆Cp of -84 
cal mol-1 K1. This value is comparable with those of other DNA 
intercalators and is consistent with the release of water through a 25 
hydrophobic interaction. Unexpectedly, the temperature variance 
of ∆H and ∆S for 92+ was found to be much higher, leading to a 
large ∆Cp (-219 cal mol-1 K1). This distinctive temperature 
response means that at 10°C the DNA binding thermodynamics for 
92+ are almost identical to those for 22+, suggesting that at the lower 30 
temperature 92+ becomes an intercalator. This was confirmed by 
viscosity experiments and the remarkable observation that at 10°C 
92+ does display a light-switch effect. What is more, once 
intercalated, the complex continues to luminesce even when the 
ambient temperature is raised to 25°C.52 35 
 As small changes in the structure of 22+ and its mononuclear 
derivatives produced such large differences in DNA recognition 
properties, we set out to explore whether similar effects modulate 
the binding properties of their dinuclear analogues.   
Making the right links with dinuclear Ru(dppz) systems. 40 
 The fact that the photophysical and biophysical properties of 82+ 
are very similar to 22+ whilst 92+ are radically different was 
striking. This observation prompted us to synthesize a series of 
eight mono- and dinuclear complexes in which tethers were 
attached to the 3- or 4- position of the coordinated pyridyl units of 45 
the bridging ligand – Fig 6  
 
Fig. 6. Ligands used in the synthesis of a series of mono- and dinuclear 
RuII complexes, analogous to those shown in Fig 4, designed to 
investigate the effect of tethering moiety on DNA binding properties. In 50 
4-py derivatives X = N, Y = CH; in 3-py derivatives X = CH, Y = N 
 The connecting tethers possessed potential DNA recognition 
sites in themselves and were also chosen to investigate the effects 
of linker rigidity on the binding properties of resultant metallo-
intercalators.53 Although simple absorption-based DNA titrations 55 
indicated that the mono- and dinuclear complexes containing the 
central aromatic ring in its linker bind to DNA with higher 
affinities, more profound differences were revealed in viscosity 
experiments.  
 All mono- and dinuclear complexes containing 4-py based 60 
ligands induced increases in the relative viscosity of aqueous DNA 
solutions, providing prima facie evidence of intercalation.  The 
complexes containing the more flexible 4py-x-4py induced larger 
changes than the 4py-Y-4py-based complexes. Furthermore, 
unlike the mono- and dinuclear 4py-Y-4py-complexes, which both 65 
had very similar effects on viscosity; the mononuclear 4py-x-4py 
complex induced appreciably larger changes than its dinuclear 
analogue, changes that approached those caused by the 
archetypical intercalator ethidium bromide. In contrasts, all the 
complexes containing 3-py based ligands produce large increases 70 
in viscosity, comparable or greater than ethidium bromide and the 
dinuclear complexes induce changes that are comparable or larger 
than their mononuclear equivalents. 
 These results provided further evidence that substituents in the 
4-position of the coordinating pyridyl moiety modulate the tight 75 
intrinsic binding properties of the Ru-dppz intercalative platform 
much more than 3-py analogues.  
 ITC was then used to investigate this issue in more detail. This 
analysis showed that three of the complexes containing 4-py based 
ligands showed similar thermodynamic signatures indicative of 80 
entropy-driven binding. However, one dinuclear complex, 
displayed a very different thermodynamic profile, with binding 
being enthalpy driven and entropy opposed. Within this group, the 
ITC-measured binding constants for the dinuclear complexes were 
actually lower than that for the corresponding monomeric complex 85 
and binding site size remained more or less constant. 
 The 3-py-linked complexes display very different binding 
thermodynamics. The dinuclear complexes have higher affinities 
for DNA than their corresponding mononuclear complexes, with 
affinities up to two orders of magnitude larger than ITC-based 90 
estimates obtained for 44+ and 52+. Further analysis of the data 
suggested that these complexes bind to DNA with mixed groove 
binding/intercalative interactions. Clearly, these studies confirmed 
that the nature of the tether ligand can greatly modulate the binding 
properties of our linked systems. 95 
Heteroleptic Ru(dppz/dppn) systems. 
 In the course of identifying new building blocks for our 
oligonuclear systems, we discovered that RuII(dppn) complexes 
possess interesting properties that are quite different to their 
RuII(dppz) analogues. 100 
  In the 1990s the Barton group had reported that despite binding 
DNA with affinities that are comparable to DNA light-switch 
systems, [Ru(bpy)2(dppn)]2+ (dppn = benzo[i]dipyrido[3,2-a:2′,3′-
c]phenazine) is not luminescent, even when bound.54 Over a 
decade later, we found that a range of complexes containing the 105 
RuII(dppn) moiety were all virtually non-emissive in any solvent. 
This prompted us to investigate the excited state properties of 
complexes like [Ru(bpy)2(dppn)]2+ in more detail.  
 Transient absorption spectroscopy showed that all the 
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complexes containing the RuII(dppn) unit displayed a long-lived 
dppn-based ππ* triplet state, which is an efficient singlet oxygen 
sensitizer, producing 1O2 yields of >70%.55 This observation 
suggested that such complexes could be useful as sensitizers for 
photodynamic therapy. PDT. Later work by the Turro group 5 
confirmed this suggestion. In a detailed study they showed that 
photoexcitation of [Ru(bpy)2(dppn)]2+ results in occupation of two 
excited states: the ππ* state we described, and a strongly oxidizing 
3MLCT state capable of directly photo-damaging G-sites of 
DNA.56 Prompted by these encouraging observations we 10 
investigated the properties of dinuclear complexes that 
incorporated the RuII(dppn) moiety. 
 By modifying Scheme 1, mononuclear complex 112+ was used 
to synthesize 124+ and its heteroleptic dppz/dppn analogue 134+ - 
Fig. 7. The properties of the three new complexes were then 15 
compared to those of their dinuclear Ru(dppz) analogue.57 All four 
complexes had comparable DNA binding affinities, but their 
photophysical properties are strikingly different. Whereas the 
singlet oxygen yield on photoexcitation of the homoleptic 
dinuclear RuII(dppz) complex was very low (~4%), the comparable 20 
estimate for 124+ was almost 70%. Interestingly, for 134+, an 
intermediate figure of ~16% was obtained even though this 
complex still displayed a DNA light-switch effect. These latter 
observations are consistent with occupation and equilibration 
between a dppn-based 
3* state and a shorter lived RuIIdppz-25 
based 
3
MLCT state.  
 
Fig 7 Structure of mono and dinuclear complexes containing the 
RuII(dppn) fragment used in PDT studies.  
 The live cell uptake properties of these complexes were also 30 
surprisingly different. In cell ruthenium concentrations after 
exposure to each complex were directly measured using 
inductively coupled plasma mass spectrometry (ICP-MS). This 
analysis revealed that although all three complexes are internalized 
by cells, the intracellular accumulation of both dinuclear 35 
ruthenium complexes are notably higher than that of the 
mononuclear complexes. Interestingly, while the uptake of 
heteroleptic complex 214+ is around x7 that of 192+ the comparable 
figure for homoleptic complex
 
204+ is x65. This indicates that the 
lower charge density and higher lipophilicity of the oligonuclear 40 
systems relative to the mononuclear complex are determinants of 
uptake. The luminescent properties of 204+ were exploited to 
investigate its intracellular localisation through confocal laser 
scanning microscopy, CLSM, which revealed that the complex 
localizes within mitochondria and particularly lysosomes – Fig 8.  45 
 As expected from their live cell uptake and high singlet oxygen 
sensitization properties the complexes are promising leads for 
photodynamic therapy, PDT. Studies involving the A2780 human 
ovarian cancer line showed that all three complexes are phototoxic, 
but - perhaps due to its better uptake properties - complex 204+ has 50 
the most potent activity; even using low light fluences (14 J cm-2) 
the complex displays a phototoxic index (PI) of >200.  
Interestingly, these effects are potentiated in the related cisplatin-
resistant A2780cis cell-line, in which PIs of up to 1000 were 
observed. These promising studies suggest that derivatives of 204+ 55 
and 214+ could be exploited as PDT sensitizers, particularly if they 
can be adapted to be photo-excited with lower energy light sources 
that provide high tissue penetration. 
 
Fig 8. A: A2780 cells showing emission from [13]Cl4, B: Emission from 60 
lysotracker deep red C: Merged co-localization image. E: A2780 cell 
viability data for complexes [[12]Cl4, upon irradiation. Adapted with 
permission from reference 57. 
Dinuclear tpphz complexes as imaging probes  
Apart from using a modular approach in the construction of linked 65 
M(dppz) systems, we have also developed complexes 
incorporating the ditopic briding ligand tetrapyridyl[3,2-a:2′,3′-
c:3′′,2′′-h:2′′′,3′′′-j]-phenazine (tpphz). In these studies the 
photophysical and biological properties of rigid MtpphzM units are 
modulated by the choice of metal ion and nature of the ancillary 70 
ligands coordinated to the two metals. This work first began 
through the aim of developing a light-switch complex for a specific 
non-canonical DNA structure.  
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The first quadruplex DNA light-switch. 
It has been known for many years that in the right conditions G-
rich DNA can form four-stranded structures58 but over the last two 
decades the structure and possible functions of such quadruplexes 
within living cells have attracted more and more attention. 59-62 5 
Current studies indicate that quadruplex structures are ubiquitous 
within cells and they have been associated with an almost 
bewildering range of functions including; determination of 
Hayflick limits, replication initiation, transcription switching, 
epigenetics, and genetic disease. However, there are still many 10 
unanswered questions on the in-cell occurrence, dynamics, and 
function of these fascinating structures. 
 When we first began our work in this area the presence of 
quadruplexes within a cell environment was still a moot point. So, 
the idea of a probe that produced a distinctive signal only when 15 
bound to a quadruplex structure was an attractive goal and it 
seemed possible that an adapted DNA light-switch complex might 
just meet these requirements. 
 A consideration of the distinctive structure of the G-tetrad that 
forms the basis of all quadruplexes, led to the conclusions that a 20 
more extended version of the dppz ligand would provide an 
appropriate aromatic stacking surface, whilst a dinuclear RuII 
complex would provide cationic centres to coulombically interact 
with the anionic phosphate residues of the quadruplex backbone. 
Using these simple selection criteria, a small group of previously 25 
reported complexes - in particular 144+ and 154+, Fig. 9,63 which 
incorporated the tpphz - were identified as potential leads. 
 Studies on this small library revealed that when 144+ and 154+ 
bind to duplex DNA they display a light-switch effect in which a 
broad emission band at ~670 nm increases by ×60.64 Their 30 
emission properties on exposure to quadruplex structures are more 
complex. 
 
Fig 9 Dinuclear complexes investigated as DNA Probes 
 Although the complexes display virtually no increase in 35 
emission on binding to structures with lateral loops, binding to 
quadruplex structures containing external lateral loops is 
accompanied by a ×150 increase in emission intensity which is also 
blue shifted to ~635 nm. Analysis of these luminescence changes 
also reveals a range of binding properties.  Whilst the complexes 40 
bind to duplex DNA with affinities of ~106 M-1, equivalent figures 
for their interactions with quadruplexes vary over three orders of 
magnitudes.  For example, binding of 144+ to the thrombin binding 
aptamer – an unimolecular structure with a single lateral loop - 
results in a estimated Kb of ~104 M-1 but its affinity for the 45 
antiparallel-folded human telomere structure, HTS, is >107 M-1.65 
Consequently, the molecular basis for these distinctive selectivities 
was investigated  
 We initially suggested that the complexes may intercalate into 
duplex DNA,64  perhaps through the threading interaction first 50 
reported by Lincoln and Nordén in their investigations on their 
similar, more extended, analogues. However, later studies by 
Dunbar and Turro demonstrated that 144+ does not spontaneously 
intercalate into genomic duplex DNA, even when added to single 
stranded DNA as it anneals into a duplex, indicating that the 55 
complexes groove-bind to extended double-stranded sequences.66 
 Very recently, we carried out detailed NMR experiments on the 
interaction of the three individual stereoisomers of 144+ with the 
octanucleotide duplex sequence; 
d(GCATATCG).d(CGATATGC). Surprisingly, we found that the 60 
Λ,Λ and Δ,Λ isomers bound to the centre of the octanucleotide by 
threaded intercalation– Fig 10A; yet, the Δ,Δ form displayed two 
bound states in intermediate exchange on the NMR timescale, 
suggesting a dynamic exchange between minor groove binding and 
intercalation. We concluded that although the complex does 65 
groove bind to stable duplexes, it is capable of threading into less 
stable, or more flexible, sequences.67  
 Similar experiments revealed that chirality is also an important 
factor in the interaction of these complexes with the antiparallel 
HTS sequence d[AG3(TTAG3)3]. Prompted by the observation that 70 
Δ,Δ-154+ binds to HTS  with a relatively low affinity (Kb = 3 × 105 
M-1), but Kb for Λ,Λ-154+ is >107 M-1, a combined NMR and 
computational analysis using 144+ showed that while both Δ,Δ-144+ 
and Λ,Λ-154+ bind to HTS by stacking onto the G-tetrad at the 
lateral loop end of the structure, only the Λ,Λ stereoisomer can 75 
thread through the diagonal loop over the tetrad at the other end of 
the quadruplex - Fig 10B. Hence, it was concluded that this 
threading interaction is responsible for the higher HTS-binding 
affinity of the Λ,Λ stereoisomer.68 CLSM studies on the cell uptake 
of 144+ and 154+ also produced striking results.  80 
 
Fig. 10 Left: NMR-based structure for the major conformation of 144+ 
threaded into the duplex sequence d(GCATATCG)2. Right: NMR-based 
structure of 144+ threaded into the HTS d[AG3(TTAG3)3] sequence folded 
into an antiparallel quadruplex . Adapted with permission from references 85 
67 and 68, respectively. 
 Initial experiments, with complex 144+, produced disappointing 
results as this complex is only internalized by fixed or dead cells. 
Remarkably, however, in the same conditions 154+ is rapidly taken 
up by commonly used cultures such as MCF-7, CHO, and A2780 90 
cell-lines, but displays very low cytotoxicity (IC50 after 24 hours = 
138 M). Furthermore, binding to nuclear DNA was revealed in 
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CLSM images demonstrating that, thanks to its DNA light-switch 
response, 154+ is an excellent luminescent probe for chromatin -
Fig 11. 
 
Fig. 11 Confocal microscopy images using two separate detection 5 
channels 670-700 nm (red) and 630-640 nm (yellow) show the multiple 
emission profile of nuclear luminescence  from L5178Y-R cells (which 
have extended G-rich telomeric DNA) stained with 154+ Top Left: 670-
700 nm channel Top middle: 630-640 nm channel. Top Right Overlayed 
image. Bottom: L5178-R metaphase cells with chromosomes showing 10 
specific localisation of the 630-640 nm emission peaks.  Adapted with 
permission from reference 69. 
Indeed, the complex is well suited to this application: as it is 
chemically and photochemically stable it does not photo-bleach 
and its large Stokes shift - with an emission in the red/NIR - 15 
reduces “crosstalk” from the excitation source and endogenous 
luminophores. Co-localization studies with the general nucleic 
acid probe, SYTO 9, confirmed that the complex images DNA but 
not RNA and it was also found that the complex is internalized by 
an energy-dependent mechanism that does not involve 20 
endocyctosis or pinocytosis. 69  
 More interestingly still, lambda-stacking experiments showed 
that the internalized complex displayed two emission maxima - 
centred at ~680 nm and ~630 nm respectively - which correlated 
with the duplex and quadruplex light-switch effects in cell-free 25 
studies. By defining separate 670–700 nm and 630–640 nm 
channels it became clear that the red-shifted emission was 
consistent with general chromatin staining, but the blue-shifted 
emission was from specific areas within nuclei and did not co-
localize with the other channel. Several experimental lines, 30 
including imaging cells lines with differing telomere lengths, 
provided evidence that this distinctive higher-energy emission is a 
marker for quadruplex DNA within live cells – Fig 11. 
TEM Probes. 
The most commonly employed contrast stain for TEM is a far-35 
from-ideal reagent. Osmium tetroxide is used to visualise 
intracellular structure as it densely stains membranes. However, it 
is extremely toxic and highly volatile; even at very low exposures 
(0.1 mg/m3) it can cause visual disturbances, headaches, and even 
conjunctivitis, yet alternative TEM stains are virtually unreported.  40 
 As complex 154+ contains two electron-dense RuII ions, it 
seemed likely that the complex or derivatives could have 
considerable potential as a contrast stain for this technique. An 
added attraction of such complexes is their handling convenience. 
In contrast to OsO4., 154+ and its derivatives have very low 45 
toxicities, possess low reactivity and volatility, and display 
excellent water solubility Studies on cells treated with 154+ 
confirmed that the intracellular localisation of the complex at high 
spatial resolution can be determined through TEM;69 however, to 
obtain enhanced TEM imaging capabilities, its OsII derivatives, 50 
164+ (Fig 9) was investigated. Consistent with the energy gap law, 
due to its lowered excited state energy, this complex+ is non-
emissive; however, the inclusion of two third row transition metal 
ions means that it is an even more effective contrast stain than its 
RuII analogue. 55 
 
Fig. 12 Left: TEM image of a MCF7 cell nucleus stained with 164+. 
Right: Detailed image of nuclear membrane structure, showing nuclear 
pore complex. Key: pm = plasma membrane, nm = nuclear membrane, N 
= nucleus, C = cytosol, n = nucleolus, m = mitochondria, het = 60 
hetrochromatin, np = nuclear pore complex. Adapted with permission 
from reference 70. 
 It was found that staining was achieved in previously fixed cells 
but also in live cells that were fixed after treatment with the 
complex. In either case, cells stained with 164+ display excellent 65 
levels of intracellular contrast, which facilities the visualisation of 
cellular detail at resolutions entirely comparable to those obtained 
by OsO4. For example, visualisation of nuclear pore complexes 
(~120 nm) which are responsible for transport of molecules across 
the nuclear membrane are clearly visualized – Fig 12. 70 70 
 It was also found that the subcellular localisation of 144+ - 164+ 
can be selected for by judicious selection of ancillary ligands. A 
derivative of the parent complexes, 174+ (Fig 9), containing the 4,7-
diphenyl-1,10-phenanthroline, DIP, was designed to localize 
within lipid rich, membrane structures.  The inclusion of this ligand 75 
has two effects. First, the greater steric bulk of DIP inhibits the 
ability of the complex to groove-bind with duplex DNA resulting 
in a lower binding affinity compared to 144+ and 154+. Second, the 
ligand increased the lipophilicity of 174+, which was demonstrated 
in cell-free experiments using liposomes. The complex 80 
demonstrated a clear increase in luminescence when interacting 
with liposomes, whereas 154+ displayed no equivalent change in 
luminescence.  Consequent CLSM studies with fixed cells 
revealed that MCF7 cells exposed to 174+ displayed pronounced 
staining of the nuclear membrane and perinuclear space, whilst 85 
detailed immunofluorescent co-staining techniques confirmed the 
complex preferentially stained the lipid-rich endoplasmic 
reticulum over the Golgi apparatus – Fig 13.71 
 Of course, an additional advantage of 174+ over conventional 
ER probes is its additional function as a TEM contrast stain and 90 
experiments using this technique showed that it could also be used 
to image mitochondrial inner membrane structure. However, this 
change in subcellular localization was accompanied by a 
concomitant increase in live-cell cytotoxicity. 
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Fig. 13 Co-staining of MCF7 cells Left: ER-localized Calnexin protein 
visualized by immunofluorescence (FITC-conjugated secondary 
antibody) Centre: emission from 174+ Right: merged images. Adapted 
with permission from reference 71. 5 
Exploring charge effects in localisation 
In the last two decades, research into polypyridyl IrIII-based 
complexes for a variety of light-driven applications has rapidly 
grown. Thanks to large spin-orbit coupling effects these 
luminophores possess high triplet state conversion efficiencies.  10 
Moreover, by coordinating conventional and cyclometalating 
ligands to the IrIII centre, mixing of MLCT and LLCT (ligand-to-
ligand charge-transfer) states can occur, thereby providing a 
method to tune the excited state properties of these systems.72 Yet, 
when we began our work, there were surprisingly few examples of 15 
DNA targeting IrIII cell probes, probably due to the poor aqueous 
solubility of cyclometalated systems, which commonly possess 
low cationic charge. To address this issue, we synthesized 
heteronuclear IrIIIRuII complexes. By incorporating cyclometalated 
ligands complexes that are isostructural with 144+ and 154+ but with 20 
lower overall charges could be obtained. Using this approach, 183+, 
193+, and 203+ were obtained - Fig 14.73,74 
 
Fig 14 Structures of IrIIRuII complexes 183+ - 203+ with modified uptake 
properties compared to 154+. 25 
 Although their emission properties are similar to their RuIIRuII 
analogues - indicating that the lowest excited state of these 
complexes is centred on their Ru(bipy)2(tpphz) moiety - they have 
very different biophysical and cell uptake properties. Two of the 
complexes (183+ and 193+) bind to duplex DNA with affinities that 30 
are an order of magnitude lower than 144+ and 154+, suggesting that 
Coulombic effects play a significant role in these interactions.73 
Yet, the estimated binding parameters for complex 203+ are very 
similar to those of 154+. This suggests that the additional 
hydrophobic and/or stacking interactions provided by the more 35 
extended and rigid ancillary ligands of 203+ delivers key additional 
contributions to the binding thermodynamics of this complex.74 
 A CLSM comparison of the cell uptake properties of 144+, 183+ 
and 193+, which are close structural analogues, is particularly 
interesting. Unlike 144+ both 183+ and 193+ are internalized by live 40 
HeLa cells and function as luminescent stains for chromatin. These 
facts suggest that the lower charge of the heterometallic species 
facilitate cellular uptake, particularly as cells are brightly stained 
at concentrations that are lower than those required for imaging by 
154+. Importantly, in contrast to many examples where increased 45 
lipophilicity is accompanied by a change in sub-cellular targeting, 
vide infra, this improved cellular uptake occurs without loss of 
nuclear localisation Moreover, analysis of luminescent intensities 
indicates that complex 193+, which contains fluorinated ancillary 
ligands, shows improved uptake and nuclear localisation compared 50 
to its non-fluorinated analogue.73 This observation is an example 
of a well-known effect exploited in classical medicinal chemistry, 
in which fluorination is used to increase the cell permeability of a 
pharmaceutical. 
  However, the combination of lowered charge and the more 55 
rigid, extended ancillary ligands of 203+ do begin to affect its 
biomolecular targeting properties. Whilst the complex does very 
effectively stain nuclear DNA in fixed cells, initial attempts at live 
cell staining produced very disappointing results as incubation of 
MCF7 cells with the complex for periods as long as 24 hours 60 
resulted in poor, non-specific intracellular emission and no nuclear 
staining. This effect was found to be caused to one of the 
components of the culture the cells were grown in.  
 A number of metal complexes have been shown to interact with 
serum proteins, and some have even been developed as optical 65 
probes for serum albumins. As bovine serum albumin, BSA, is a 
ubiquitous constituent of cell cultures its interaction with 203+ in 
cell-free conditions was investigated. It was found that this 
complex bound to Sudlow site I of BSA, a hydrophobic cavity 
which is known to bind hydrophobic drugs. Subsequent exposure 70 
of cells to low concentrations of 203+ in serum-free conditions 
resulted in rapid uptake of the complex and CLSM revealed well-
defined nuclear localisation, but there was also a concomitant 
increase in the apparent cytotoxicity of the complex.74  
 As pointed out in the original report, these observations have 75 
implications for the design of potential therapeutics and imaging 
probes; structural changes aimed at increasing permeability 
through enhanced lipophilicity may actually adversely affect the 
ability of such agents to reach their therapeutic targets when they 
are surrounded by blood serum proteins.  80 
Exploiting advanced imaging techniques 
Thanks to diffraction effects first described by Abbé, all optical 
microscopy techniques, including CLSM - which offers 
considerable improvements signal-to-noise and resolutions 
compared to conventional epifluorescence microscopy - have 85 
spatial resolutions restricted to half the wavelength of their 
imaging light. In recent years, several novel techniques have 
been developed to address these drawbacks and recent 
reports from our lab has shown how 154+ can be used as a probe 
for several of these emerging techniques.  90 
 Lifetime based, time-resolved emission imaging microscopy, 
TREM, offer several advantages over conventional intensity-based 
technologies as it provides information on the probe environment 
independent of its concentration. Furthermore, if TREM employs 
phosphorescence probes that emit on the hundreds of nanoseconds 95 
to microsecond timescale, this technique completely removes 
interference from biomolecular autofluorescence which typically 
has lifetimes from picosecond to <10 nanoseconds. Two-photon 
absorption, 2PA, microscopy is another technique that offers 
several advantages over conventional optical methods. As 2PA is 100 
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dependent on the square of light intensity, excitation of probes is 
highly focused, resulting in excellent spatial resolution. 
Furthermore, 2PA microscopy is particularly attractive for live 
cell-based samples as low-energy excitation wavelengths within 
the biological optical window can be used. Through the 5 
identification of probes with suitable properties, the 
advantages of these two modalities can be combined in TPA-
TREM. As the 3MLCT-based light-switch effect demonstrated by 
144+ and 154+ leads to increases in emission lifetime as well as 
intensity, it seemed likely that they could function as lifetime 10 
probes for intracellular DNA. 
 The 2PA cross-sections, , for both complexes was found to be 
appreciable, with estimated values of  =108 GM for 144+ and  
=142 GM for 154+ being obtained; values that comparable with 
other RuII-based complexes specifically synthesized to display 15 
high 2PA cross sections. These encouraging results prompted us to 
undertake lifetime microscopy studies under 2PA conditions. 75 
 In live MCF-7 or HaCat cells treated with 154+ and excited with 
800 nm light in a 2PA regime, emission from nuclei displayed a 
characteristic lifetime of 175 ns – Fig. 15A. Metaphase spreads of 20 
chromosomes derived from HeLa stained with either 224+ and 234+ 
allowed visualization of condensed chromosomal DNA with 
recorded lifetimes being in excellent agreement with those from 
live cells, indicating that in both environments the complexes are 
bound to DNA in the same way. Intriguingly, detailed analysis of 25 
the intracellular data from the complexes in fixed and live cells 
revealed a second shorter emission life-time (110 nm for 154+) 
localised within the cytoplasm, implying a specific binding site 
within this region – Fig. 15B. The longer lifetime from the nucleus 
implies that protection from surrounding water molecules in DNA-30 
bound sites is more effective than in the cytoplasm and explains 
why cytosolic emission was not observed through confocal 
microscopy; exposure to bulk water will increase excited-state 
quenching of the complexes producing greatly reduced emission 
quantum yields and intensities. These experiments illustrate how 35 
new information can be derived from lifetime imaging techniques. 
The identity of the cytoplasmic signal was subsequently 
determined using super-resolution microscopy, SRM.  
 
Fig 15 A. A comparison of lifetime and intensity imaging of live MCF-7 40 
cells pretreated with complex 154+ showing single nuclear lifetime B. 
Lifetime imaging of  fixed, permeabilized MCF7 cells treated with 
complex 154+ showing different lifetimes in the nucleus(a) and 
cytoplasm(b). Adapted with permission from reference 75. 
 One approach to SRM is stimulated emission depletion (STED) 45 
microscopy. In STED, selective deactivation of a photo-excited 
dye molecule using a depletion beam can provide excellent spatial 
resolution (below 30 nm), but does require a luminophore with 
high photostability.76 Given the known photo-stability of 
luminescent RuII complexes, we investigated the application of 50 
154+ for SRM. 
 A series of TEM and optical imaging experiments revealed, that 
apart from nuclear staining, the complex is also internalized within 
the inter-membrane space of mitochondria. In fact, at lower 
treatment concentrations (<10 M) 154+ exclusively localizes 55 
within mitochondria. As 154+ displays a low phototoxicity even 
under continuous irradiation, has a long-lived emission (which 
increases the probability of stimulated emission), and a large Stoke 
Shift (which minimizes self-quenching even at high dye loading), 
its use as a STED probe was also investigated. 77 60 
 Through a collaboration with Jorge Bernardino de la Serna at 
RAL (now at Imperial College, London), we found that by using a 
775 nm depletion beam excellent STED images of suitably treated 
live cells could be produced. At low concentrations (~6 M) 
specific imaging of mitochondria were successfully accomplished 65 
at resolutions <50 nm and at higher concentrations striking images 
of chromatin were obtained, and resolutions below 50 nm were still 
maintained – Fig 16 A - C.  
 
Fig 16 A. STED image showing staining of mitochondria in a MCF7 cell 70 
at low 154+ concentration B. STED image of a single cell showing 
chromatin staining by 154+ at higher concentration (red), with 
mitochondria co-stained by a mitotracker dye (green).  C. Magnified 
STED image showing chromosomal details D. 3D-STED super-resolved 
reconstruction of a single whole A2780 cell nucleus. Adapted with 75 
permission from reference 77.  
 With these successes in hand, the use of 154+ in 3D-STED was 
investigated. This method requires highly photo-stable probe as the 
optical sectioning used to generate 3D images means that it must 
be photostable under prolonged irradiation – conditions that often 80 
lead to photobleaching of most conventional probes. The high 
photostability of 154+ under high photon fluxes proved to be a key 
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feature in obtaining 3-D images of entire organelles at STED 
resolutions. This was illustrated by a full reconstruction of a single 
nucleus that required 165 individual section planes, producing 
excellent resolution in all three axes (XY resolutions ≈ 35 nm and 
120-150nm in the Z-axis) – Fig. 16D. 5 
 Having established the versatile in-cell imaging capabilities of 
144+ and 154+ and their derivatives, the possibility of developing 
related complexes that also displayed therapeutic action was also 
investigated. These studies were inspired by the hope of 
identifying and developing genuine theranostics.  10 
Therapeutic leads from tpphz complexes 
Anticancer therapeutic leads.  
Because complexes like 144+ and 154+ possessed such interesting 
cell uptake properties, their mononuclear analogues were also 
investigated. Although the DNA light-switch properties of 212+, 15 
Fig. 17, was first reported by Tysoe, et al in 1999,78 no consequent 
cell studies had been reported. Our initial studies on this complex 
and its phen analogue, 222+, yielded some surprising results. 
 Unlike the dppz-based parent complexes, both 212+ and 222+ are 
live-cell permeant, although 222+ displays much more efficient 20 
nuclear staining, even at low concentrations. 
 As both complexes brightly stain chromatin in fixed cells, it 
seems that the reduced luminescence of 212+ observed in live cells 
is due to its poorer cellular uptake compared to 222+. More 
importantly, we found that the complexes are cytotoxic toward the 25 
A2780 human ovarian cancer cell-line and, crucially, not only is 
the potency of 222+ comparable to cisplatin, but its potency is 
retained in the cisplatin-resistant A2780cis daughter cell-line. 79 
Recently, more detailed studies involving 222+ cast light on its 
mechanism of action. 30 
 
Fig. 17 Structures of mono- and dinuclear complexes containing the tpphz 
ligand that have been developed as therapeutics. 
Proteomic analysis of cytotoxicity 
 A comparison of 222+ with non-intercalating mono- and 35 
dinuclear derivatives incorporating tpphz and a related ligand, 
showed that only 222+ displayed high therapeutic potency against 
both A2780 and A2780cis cells and, encouragingly, equivalent 
IC50 figures in the non-tumour HEK293 cell-line were found to be 
over two orders of magnitude higher than the values found for 40 
A2780cis cells. Inductively coupled plasma mass spectrometry 
(ICP-MS) experiments on 222+ and its derivatives showed that 
therapeutic activity was not simply a function of cell uptake 
concentration.as some of the less potent complexes were 
internalized at higher concentrations than 222+. Furthermore, 45 
despite all the complexes displaying considerably lowered cellular 
accumulation in A2780CIS cells compared to the parent line - 
consistent with previous studies indicating that A2780CIS cells 
possess enhanced efflux capabilities – complex 222+ still retains its 
potency.  50 
 Studies into the mechanism of cell death on exposure to 222+ 
revealed a non-apoptotic mechanism, probably involving oncosis. 
This is significant as intrinsic or acquired chemotherapy resistance 
often involves abrogation of apoptotic pathways; indeed, as a result 
of this phenomenon one-third of all solid cancers respond poorly 55 
to current treatments. To further explore the effects of exposure to 
222+ a proteomic analysis on A2780CIS cells treated with the 
complex was carried out using Stable Isotope Labelling by Amino 
Acids in Cell Culture (SILAC), By accurately quantifying changes 
in protein expression through a ratiometric method based on mass 60 
spectrometry SILAC provided a detailed picture of the cellular 
response to 222+. 
 Of the 3400 distinct proteins identified by SILAC, the 
abundance of 42 proteins was significantly altered on exposure to 
the complex, with 32 up-regulated, and 10 proteins down-65 
regulated. A significant fraction of these proteins are associated 
with processes involved in DNA replication, DNA repair, or 
checkpoint signalling associated with replication stress, but the 
largest group of proteins with altered expression levels are 
involved in cellular or mitochondrial responses to reactive oxygen 70 
species and general oxidative stress. These data indicate the 
complex provokes both DNA damage and oxidative stress 
responses in treated cells. This is significant because it is 
established that therapeutic regimes displaying more than one 
mechanism of action are less susceptible to conventional resistance 75 
mechanisms. Given this, and the fact that 222+ induces a non-
apoptotic death pathway, it was concluded that this complex and 
its analogues offer great potential as novel anticancer 
therapeutics.80  
Radio-sensitising action.  80 
 One therapeutic target for this class of complexes was identified 
to be oesophageal cancer. Treatment of this condition is 
challenging as 77% of oesophageal cancers lack p53 function, 
reducing or abrogating apoptosis as a response to DNA damage. 
Accordingly, therapeutics that induce non-apoptotic death 85 
mechanisms may be more effective treatments for oesophageal 
cancers.  
 Through a collaboration with Katherine Vallis’s group 
involving Martin Gill - an ex-member of the Thomas group - these 
facts led to an exploration of the effects of 222+ on p53-deficient 90 
oesophageal cancer cells. These studies revealed that exposure to 
222+ at its IC50 concentration led to pronounced and rapid DNA 
replication inhibition and - as observed in A2780 and A2780CIS 
cells – the complex only provoked low levels of apoptosis in OE21 
cells. Fascinating morphological changes in treated cells going 95 
through cell division were also observed. The complex induced 
chromosome misalignment and the formation of multiple 
micronuclei, indicating that the DNA damage accumulated during 
mitosis causes errors in chromosome segregation and attachment. 
Another promising observation was the complex displayed 100 
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significantly reduced activity against non-proliferative 
immortalised human small airway epithelial cells. 
 The application of 222+ as a radiosensitizer was then explored. 
It was found that, at a concentration of only 2 M, significant 
decreases in surviving cell fractions compared to radiation alone 5 
occurred, accompanied by a substantial increase in double strand 
break formation compared to single treatment regimes.81  
 Consequently, this work was extended through the use of 
nanoparticles containing Auger electron emitting 111In centres 
designed to bind to epidermal growth factor receptor, EGRF, a 10 
membrane-bound receptor over- expressed in almost 70% of 
oesophageal tumours. Studies on such systems confirmed that 
they are preferentially taken up by EGRF-overexpressing 
oesophageal cancer cells compared to normal human 
fibroblasts, displaying the expected radio-toxicity. When these 15 
nanoparticles were also loaded with 222+supplied by our lab 
these effects were more pronounced as the contributions of the 
111In Auger electron emitter and radiosensitizer were additive.82  
Toward novel phototherapeutics 
Pioneering work by the Kirsch-De Mesmaeker and Kelly groups 20 
demonstrated that coordination of electron-deficient ligands, such 
as 1,4,5,8-tetraazaphenanthrene  (TAP), on to RuII centres results 
in complexes that possess highly photo-oxidizing RuIITAP 
3MLCT excited states.83 The biophysical and photophysical 
properties of [Ru(TAP)2dppz]2+ have proven to be of particular 25 
interest. As might be expected this complex binds to DNA through 
minor groove intercalation in a manner that that closely related to 
 [Ru(phen)2dppz]2+. However, instead of displaying a light-switch 
effect, Ru(TAP)2dppz]2+ is luminescent in water and - due to  
photo-redox reactions involving the oxidation of guanine sites - its 30 
emission is quenched in the presence of DNA.84 This phenomenon 
has been used to probe DNA photodamage processes in exquisite 
detail85 and it could, potentially, form the basis of novel sensitizers 
for PDT. Unfortunately, Ru(TAP)2dppz]2+ displays poor cell 
penetration; for example, even after HeLa cells are exposed to the 35 
complex for 24 hours it is only found in their cytoplasm.86  
 To address this problem, we synthesized an iso-structural 
derivative of 154+ containing RuII(TAP)2 fragments, 234+, Fig. 17, 
in the hope that it would display the same cell uptake/localisation 
properties as the parent complex, but display photophysical 40 
properties that were more related to Ru(TAP)2dppz]2+.87 
 A combination of electrochemical and photophysical 
experiments along with DFT calculations, Fig 18A, revealed that 
photo-excitation of 234+ yields a RuIITAP 3MLCT state, which 
is emissive in organic and aqueous solutions, but is quenched by 45 
the addition of any nucleotides containing guanine sites such as 
GMP, as well as duplex and quadruplex DNA. Further optical 
studies revealed that the complex binds duplex DNA with an 
affinity that is similar to its parent compound. Although its binding 
to quadruplex was reduced compared to 154+ – presumably due to 50 
unfavourable interactions between the TAP ancillary ligands 
and external loop of this structure – a Kb of >5 x105 M-1 was still 
observed in the high salt concentrations required for quadruplex 
folding. Significantly, transient absorption spectroscopy revealed 
that photoexcitation of 234+ in the presence of quadruplex DNA 55 
and G-site-containing duplexes resulted in the emergence of a 
signal at 515 nm characteristic of the guanine radical cation 
generated through photo-oxidation by the RuIITAP 3MLCT 
excited state - Fig 18B. Given these exciting results, the cell uptake 
properties of the complex were investigated.  60 
 
Fig. 18 A: Lowest triplet structures for 234+ in MeCN. B: Selected 
transient absorption spectra for 234+ in phosphate buffer with and without 
CT-DNA and quadruplex folded HTS, showing the growth of the 
transient band at ~515 nm after 7900 ps in the presence of DNA. C:Co-65 
staining with DAPI reveals that 234+ penetrates into the nucleus of 
malignant melanoma cells. Adapted with permission from reference 87. 
 These studies focussed on melanoma - an aggressive cancer that 
can produce fatality rates high as >90%. As it displays a range of 
therapeutic resistance mechanisms, new treatments for melanoma 70 
are urgently needed and it has been suggested that PDT could be 
efficacious in this role. Therefore, in collaboration with Sheila 
MacNeil and John Haycock, the phototoxicity of 234+ toward 
human melanoma C8161 cells were investigated. As this line is 
highly invasive and spontaneously metastatic it represented a 75 
therapeutically relevant and challenging treatment target. 87 
 The complex was found to be cell permeant and co-staining with 
standard cell probes revealed that it largely localizes within the 
nuclei of live C8161 cells (Fig 18C), though some staining of 
mitochondria and lysosomes – organelles which are also targets for 80 
PDT - was also observed. In the dark, at a range of concentrations 
up to 200 M, 234+ had no detectable effect on cell viability; yet, 
irradiation at low fluences (up to a maximum of only 18 J cm-2) 
resulted in a huge drop in viability, reaching zero in optimal 
conditions. These observations confirm that 234+ could be 85 
successfully “re-engineered” to produce a novel phototherapeutic. 
By using a similar approach, antimicrobial theranostics were also 
identified. 
Antimicrobial theranostics 
The rapid emergence of antimicrobial resistance, AMR, is 90 
currently one of the greatest challenges facing healthcare globally. 
In a post-antibiotic age, a third of deaths could once again be 
attributed to untreatable infections and it has been projected that 
by 2050 AMR could be responsible for an additional 10 M 
fatalities per annum.88 Pathogenic Gram-negative bacteria present 95 
a particular challenge; no new class of antibiotics for these 
pathogens has been approved for over 50 years and only one new 
compound has entered Phase 1 trials in the last 20 years.89 
 Perhaps surprisingly, the antimicrobial activity of certain 
polypyridyl RuII complexes was established almost 70 years ago. 100 
In work before its time, the Dwyer group first showed that RuII 
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complexes containing methylated phen ligands are active against a 
range of bacteria, particularly Gram-positive species.90 With the 
emergence of AMR, such structures are being reinvestigated as 
therapeutic leads.91 The fact that oligonuclear analogues of the 
Dwyer’s original lead were found to display higher activity and 5 
appear to target bacterial cell membranes prompted us to 
investigate the possibility of developing derivatives of 144+ as 
antimicrobials. 
 Our initial study, involving 154+, 174+, and two new complexes, 
244+ and 254+(see Fig 17 for structures), investigated their activity 10 
against a wild-type strain of Gram-negative Escherichia coli, 
MG1655, a uropathogenic multi-drug resistant EC958 ST131 E. 
coli strain and a pathogenic strain of Enterococcus faecalis, V583 
(ATCC 700802); this Gram-positive bacterium is a major 
opportunistic pathogen and a leading cause of urinary tract 15 
infections. 
 It was found that whilst all the complexes had some activity 
against the therapeutically resistant bacteria, 254+ was particularly 
potent, being more bactericidal than ampicillin against the wild-
type E coli strain, a potency that was retained in the pathogenic 20 
strain and resistant E faecalis. 
 Fascinatingly, the uptake of the ruthenium complex seems - at 
least in part - to be energy dependent.  In glucose-free conditions, 
internalisation of 254+ is over two phases.  After an initial post-
exposure increase, intracellular ruthenium levels do not change for 25 
~ 20 min, after which they double to a concentration above 1 mM. 
Yet, in the presence of glucose the uptake of the complex is rapid, 
with the same final intracellular concentration of ruthenium being 
reached within 20 min. These observations suggest that after a 
period of exposure to 254+ bacterial cell wall damage occurs 30 
rendering it permeable to the complex and thus allowing passive 
uptake of the complex. As 254+ is too large for porin-mediated 
uptake (which requires molecules with masses <600 Da), this 
mechanism can be discounted. 
 As 254+retains the excellent imaging capabilities of the parent 35 
complex, its mode of action was investigated using an array of 
microscope-based methods. Through a combination of SIM and 
STED experiments, it was found that, after a 20-minute induction 
period, bacterial internalisation of 254+ could be visualized through 
its characteristic emission, but before this time, the complex 40 
largely accumulates at cellular membranes and after internalization 
it increasingly preferentially locates at the cell poles.  
 Further evidence of cell membrane damage was provided by co-
staining experiments. Alexa Fluor NHS-ester 405 is a cell 
impermeable membrane probe; but, in cells that are also exposed 45 
to 254+, NHS-ester 405 internalises. Complex-induced membrane 
damage was confirmed through an ATP leakage assay and TEM 
experiments with treated E. coli EC958 cells in which blebbing of 
the membrane, outer membrane detachment, and cell lysis were 
directly visualized – Fig 19A.  50 
 Despite the radical morphological effects on prokaryotes, MTT-
assays on human embryonic kidney cells, HEK293, yielded an 
average estimated IC50 of 135 µM, meaning that there is an 80-
fold, or larger, difference in the complex’s inhibitory concentration 
against bacteria and non-malignant human cells. This data is 55 
consistent with a toxicity screen carried out using Galleria 
mellonella. The larvae of Galleria have proven to be useful in vivo 
models which have yielded data that is at least as reliable as 
commonly used mammalian models. Galleria survival, activity, 
and melanisation scores on exposure to a range of complex 60 
concentrations showed that there was no significant negative 
effects in Galleria treated with 254+, which confirmed that - even 
at concentrations well above its MIC - the complex is not toxic to 
a live multicell organism.92 
 The observation that 254+ is particularly potent against Gram-65 
negative bacteria was intriguing. One of the major differences 
between Gram-positive and Gram-negative bacteria is, or course, 
the composition of their cell-wall and - as initial study 
demonstrated that the complex disrupted the cell-wall of a Gram-
negative pathogen – we therefore set out to examine whether there 70 
were differences in its effect on Gram-positive bacteria. In these 
studies, we used a wild type strain of Staphylococcus aureus 
(SH1000) and several resistant, pathogenic strains including a 
methicillin-resistant, MRSA, variant. We chose this bacterium 
because, as the therapeutic resistance mechanisms of specific 75 
strains are well understood, it can be used as a test-bed to explore 
the action of new antimicrobials at a molecular scale. 
 
Fig. 19 Images reveal the antimicrobial Activity of 254+. A: TEM 
experiments showing E. coli EC958 cells before treatment (Top) and the 80 
morphological changes one hour after exposure (bottom). B: TEM image 
showing wild-type S. aureus cells after one-hour exposure to 254+ 
illustrating swelling of cell walls (Top). STED nanoscopy of cells of an 
MRSA strain stained with 254+ revealing the complex is clearly retained 
on/in the cell-wall in a distinctive pattern of distribution. Adapted with 85 
permission from reference 93. 
 It was found that 254+ displayed activity against the wild-type 
SH1000 strain that was comparable to our previous studies and, 
again, there was evidence that it could be internalised through an 
active transport mechanism. Furthermore, super-resolution 90 
microscopy, TEM, and other experiments confirmed that, after ~1-
hour exposure to 254+ at concentrations above its MIC the complex 
disrupted the S Aureus cell-membrane (Fig 19B). After this period 
the complex is internalized and it binds to DNA. Although all these 
observations seemed very similar to those made with E coli, there 95 
were distinctive differences. Most notably, 3D-STED images 
showed that the complex produced a punctate pattern over the 
A B
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entire S. aureus outer surface, suggesting that the initial interaction 
of the complex with Gram-positive and Gram-negative bacteria 
may be different. 
 One distinctive feature of Gram-positive bacteria is that their 
cell-walls commonly contain the glycopolymers wall teichoic acid, 5 
WTA, and lipoteichoic acid, LTA. These molecules contain 
anionic residues and moieties that protrude from the cell wall, 
which means they are capable of binding to extracellular metal 
cations. To investigate whether 254+ binds to these cell-wall 
components to produce the observed punctate pattern, experiments 10 
on mutant S. aureus strains deficient in WTA and LTA were 
carried out. 
 An immediately striking result was the increased therapeutic 
potency of 254+ against these strains, which provided evidence that 
binding to teichoic acid affects its activity. Consistent with this 15 
hypothesis, although the familiar punctate accumulation pattern 
did not arise when one of the WTA-depleted strains of S. aureus 
was treated with 254+, brighter luminescence from the internalized 
complex was observed. Conversely, a known mechanism of 
resistance in MRSA strains is upregulation of WTA and LTA. 20 
When such a strain was treated with 254+ corresponding STED 
images revealed that, although the complex did not internalize, the 
characteristic punctate pattern on the cell wall was distinctly more 
pronounced, Fig 19B, providing further evidence that electrostatic 
binding to WTA and LTA lowers susceptibility to the complex by 25 
inhibiting its internalization. 
 Related experiments with a mprF knockout strain of S. aureus 
also led to revealing results.  This gene controls a process that 
increases positive charge on the outer surface of the S. aureus 
membrane, reducing its susceptibility to cationic antibiotics and = 30 
as might therefore be expected - it was found that the mprF knock-
out was considerably more susceptible to 254+ than any of the other 
strains employed in the study. 93 
It was concluded that the identification of these resistance within 
Gram-positive bacteria would facilitate the synthesis of future 35 
derivatives designed to mitigate their deleterious effects on the 
therapeutic action of 254+. 
A self-assembled sensitizer for PDT 
Over the last two decades, interest in metal-directed self-assembly 
of macrocycles and cages has massively grown. Right from the 40 
beginning such studies focussed on the design of hosts, and sensors 
for a variety of molecular substrates. 94,95 Yet, it is only recently 
that the bioactivity of these architectures has begun to be 
examined. 96 In the early days of such studies, we began to 
investigate the potential of luminescent heterometallic structures 45 
as binding substrates for biomolecules. 97,98  
 A Ru2Re2 macrocycle, 334+, was identified as a promising lead 
for such work. As it had already been determined that the 
macrocycle was a host for simple anions in non-aqueous solvents 
- and its crystal structure revealed that it has a “cupped palm” 50 
structure, Fig 20A and B, 98 that has some structural resemblance 
to the binding site of a DNA binding transcription factor TATA 
box binding protein, TBP - the DNA binding properties of 334+ in 
water was investigated. 
 It was found that the macrocycle recognizes duplex DNA with 55 
high affinities (>106 M-1) and, like TBP, it induces pronounced 
duplex bending. Given that 334+ is incapable of intercalating, it was 
concluded that the macrocycle must externally bind to DNA 
through a motif that is similar to that of TBP. 99,100 These 
observations prompted progression to cell-based studies. 60 
 
Fig 20 A Macrocycle 264+ B Detail of X-ray structure of [26](PF6)4 
showing the structure of the 264+ cation. C Swollen morphology of 
irradiated live MCF7 cell pre-treated with [26]Cl  100 minutes after 
exposure D Time dependent emission profile of the cell showing increase 65 
in intensity from the nucleus, particularly the  nucleolus, after initial 
plasma membrane staining. Adapted from references 98 and 101 with 
permission. 
 Fixed MCF7 breast cancer cells treated with 264+ did exhibit 
non-specific nuclear staining, but bright emission from lipid rich 70 
regions of the cell, such as the nuclear membrane and endoplasmic 
reticulum was also observed. However, equivalent treatment of 
live cells led to very different results. After 20 minutes exposure to 
the macrocycle, cells were placed in fresh, complex-free, media 
and any emission from 264+ was monitored by CLSM. Initially, 75 
only membrane staining occurred; but, within an hour, emission 
from nuclei and particularly nucleoli was observed. This was then 
followed by slower general staining of the nuclear membrane and 
other membrane-enclosed structures in the cytoplasm such as 
endosomes, lysosomes, and the ER. This last change in emission 80 
localization was accompanied by cell swelling characteristic of 
oncosis. – Fig 20C and D As these effects were only observed 
following exposing the treated cell to light, indicating that 334+ is 
phototoxic, the ability of the macrocycle to generate singlet oxygen 
on photoexcitation was investigated.  85 
 Interestingly, despite the fact that 272+ - the mononuclear RuII 
complex used as a “building block” to construct the macrocycle - 
is actually a better 1O2 sensitizer than 264+ ((1O2) = 54 ± 5 % for 
the macrocycle and 75 ± 2 % for 272+, respectively) it does not 
display the same potent phototoxicity as 274+. This apparent 90 
anomaly was resolved by ICP-MS data, which showed that 
intracellular ruthenium concentrations were approximately seven 
times higher on treatment with the macrocycle as opposed to 272+. 
Thus, the striking PDT properties of 264+ are, at least in part, due 
to its enhanced cell uptake properties compared to the mononuclear 95 
complex. Presumably, the lower charge density of the macrocycle 
increases its lipophilicity compared to 272+.101 
 This first report of a metal-ion templated self-assembled 
sensitizer offered a new paradigm for PDT because the 
photophysical and biophysical properties of such architectures can 100 
be optimized using relatively simple, mononuclear complex as 
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Conclusions 
The work outlined in this review demonstrates how bio-functional 
structures can be developed through the judicious selection of 
specific transition metal ions and ligands. As illustrated by the 
examples discussed herein this approach can be developed to 5 
create new optical probes, therapeutics, phototherapeutic and 
theranostics. Furthermore, because the synthesis of these new 
oligonuclear complexes is essentially modular in nature, they can 
be readily accessed through relatively simple synthetic methods 
that, if required, can provide multigram quantities. Through the 10 
judicious selection of metal and ligand components, the structure 
and function of these lead molecules can be easily further 
developed through iteration so that species with highly specific 
targets and function can be evolved. The inclusion of metal centres 
into these species provides a spectrum of imaging modalities to 15 
facilitate the identification of action mechanisms of such 
therapeutic leads.  
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